13
3.3.3 Specific References
There are ten specific references for this technique:
Gehl, Julie, Thesis, Copenhagen, May 2002
Roos A-K, Moreno S, Leder C, Pavlenko M, King A, Pisa P. Enhancement of cellular immune response to a
prostate cancer DNA vaccine by intradermal electroporation. Molecular Therapy, 2006. 13; 320-327.
Biragyn A, Schiavo R, Olkhanud P, Sumitomo K, King A, McCain M, Indig FE, Almanzar G, Baatar D. Tumor-
associated embryonic antigen-expressing vaccines that target CCR6 elicit potent CD8+ T cell-mediated
protective and therapeutic antitumor immunity. J Immunol. 2007 Jul 15;179(2):1381-8.
Roos A-K, King A, Pisa P. DNA vaccination for prostate cancer. Electroporation protocols: Experimental and
Clinical Medicine. Editor S. Li © Humana Press Inc., Totowa, NJ. Methods Mol Biol. 2008;423:463-72.
Vertuani, S, Triulzi, C, Roos, A-K, Pisa, P, Charo, J, Lemonnier, F, Nishimura, M, Seliger, S, Kiessling,
R. HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor
recognition upon DNA vaccination in HLA-A2 transgenic mice. 2008. Cancer Immunol Immunother. 2009
May;58(5):653-64. Epub 2008 Sep 27.
Lundberg K, Roos A-K, Pavlenko M, Wehrum D, Pisa P. A modified epitope identified for generation and
monitoring of PSA-specific T cells in patients on early phases of PSA-based immunotherapeutic protocols.
Vaccine. 2009 Mar 4;27(10):1557-65.
Bråve A, Hallengärd D, Gudmundsdotter L, Stout R, Walters R, Wahren B, Hallermalm K. Late administration
of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to
carcinoembryonic antigen. Vaccine. 2009 Jun 8;27(28):3692-6. Epub 2009 May 3.
Roos, A-K, Eriksson, F, Walters, D, Pisa, P, King, A. Optimization of skin electroporation in mice to increase
tolerability of DNA vaccine delivery to patients. Molecular Therapy, 2009 Sep;17(9):1637-42. Epub 2009 Jun
16.
Lladser A, Ljungberg K, Tufvesson H, Tazzari M, Roos A, Quest FG, Kiessling R. Intradermal electroporation
with a survivin DNA vaccine induces CTLs against a self-epitope, suppresses angiogenesis and confers long-
term protection against mouse melanoma. Cancer Immunol Immunother. 2009 Jun 14. [Epub ahead of print]
Roos A-K, Eriksson E, Timmons J, Gerhardt J, Nyman U, Gudmundsdotter L, Bråve A, Wahren B, Pisa P. Skin
Electroporation: Effects on Transgene Expression, DNA Persistence and Local Tissue Environment. PLoS ONE.
2009 Sept 30.
AgilePulse
™
Tutorial
3
